{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:30:15Z","timestamp":1748971815798,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo","doi-asserted-by":"publisher","award":["08072320"],"award-info":[{"award-number":["08072320"]}],"id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s13318-021-00690-4","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T16:02:43Z","timestamp":1625587363000},"page":"547-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Daptomycin Pharmacokinetics and Pharmacodynamics in Patients on Methadone Substitution Therapy"],"prefix":"10.1007","volume":"46","author":[{"given":"Simona","family":"De Gregori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"De Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Delfina","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzina","family":"Monzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Biscarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Colaneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Gallazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5246-928X","authenticated-orcid":false,"given":"Elena","family":"Seminari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"690_CR1","doi-asserted-by":"crossref","unstructured":"Talha KM, Desimone DC, M Rizwan S, Baddour LM. Pathogen influence on epidemiology, diagnostic evaluation and management of infective endocarditis. Heart. 2020;106):1878\u201382.","DOI":"10.1136\/heartjnl-2020-317034"},{"key":"690_CR2","doi-asserted-by":"crossref","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25:362\u201386.","DOI":"10.1128\/CMR.05022-11"},{"key":"690_CR3","doi-asserted-by":"crossref","unstructured":"Akins RL, Rybak MJ. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother. 2001;45:454\u20139.","DOI":"10.1128\/AAC.45.2.454-459.2001"},{"key":"690_CR4","doi-asserted-by":"crossref","unstructured":"Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075\u2013128.","DOI":"10.1093\/eurheartj\/ehv319"},{"key":"690_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","volume":"48","author":"N Safdar","year":"2004","unstructured":"Safdar N, Andes D, Craig WA. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother. 2004;48:63\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"690_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1086\/652767","volume":"50","author":"SM Bhavnani","year":"2010","unstructured":"Bhavnani SM, Rubino CM, Ambrose PG, Drusano GL. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. Clin Infect Dis. 2010;50:1568\u201374.","journal-title":"Clin Infect Dis"},{"key":"690_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1128\/AAC.36.5.1109","volume":"36","author":"MJ Rybak","year":"1992","unstructured":"Rybak MJ, Bailey EM, Lamp KC, Kaatz GW. Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia. Antimicrob Agents Chemother. 1992;36:1109\u201314.","journal-title":"Antimicrob Agents Chemother"},{"key":"690_CR8","doi-asserted-by":"crossref","unstructured":"Pea F, Crapis M, Cojutti P, Bassetti M. Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia. Infection. 2014;42:207\u201310.","DOI":"10.1007\/s15010-013-0511-2"},{"key":"690_CR9","doi-asserted-by":"publisher","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009. https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"690_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT, Richeimer S. Actual and potential drug interactions associated with methadone. Pain Med. 2008;9:315\u201344.","journal-title":"Pain Med"},{"key":"690_CR11","doi-asserted-by":"crossref","unstructured":"Gutkowska J, Schiller PW. Renal effects of TAPP, a highly selective mu-opioid agonist. Br J Pharmacol. 1996;119:239\u201344.","DOI":"10.1111\/j.1476-5381.1996.tb15977.x"},{"key":"690_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633\u20138.","journal-title":"Clin Infect Dis"},{"key":"690_CR13","doi-asserted-by":"crossref","unstructured":"Mariani B, Corbella M, Seminari E, Sacco L, Cambieri P, Capra Marzani F, et al. Evaluation of a model to improve collection of blood cultures in patients with sepsis in the emergency room. Eur J Clin Microbiol Infect Dis. 2018;37:241\u20136.","DOI":"10.1007\/s10096-017-3122-5"},{"key":"690_CR14","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1128\/AAC.48.8.2799-2807.2004","volume":"48","author":"B Dvorchik","year":"2004","unstructured":"Dvorchik B, Arbeit RD, Chung J, Liu S, Knebel W, Kastrissios H. Population pharmacokinetics of daptomycin. Antimicrob Agents Chemother. 2004;48:2799\u2013807.","journal-title":"Antimicrob Agents Chemother"},{"key":"690_CR15","unstructured":"European Medicines Agency. Guideline on bioanalytical method validation. Avaialble from https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf. Accessed 28 May 2021"},{"key":"690_CR16","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1128\/AAC.00247-06","volume":"50","author":"M Benvenuto","year":"2006","unstructured":"Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50:3245\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"690_CR17","unstructured":"Mellors JW, Horwitz RJ, Coleman DF. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med. 1985;79:A49."},{"key":"690_CR18","doi-asserted-by":"crossref","unstructured":"Bellomo R, McEvoy S, Kai Lo S, Myburgh J, Neal B, Norton R, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the Saline versus Albumin Fluid Evaluation (SAFE) study. Br Med J. 2006;333:1044\u20136.","DOI":"10.1136\/bmj.38985.398704.7C"},{"key":"690_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijantimicag.2018.03.008","volume":"52","author":"A Soraluce","year":"2018","unstructured":"Soraluce A, As\u00edn-Prieto E, Rodr\u00edguez-Gasc\u00f3n A, Barrasa H, Maynar J, Carcelero E, et al. Population pharmacokinetics of daptomycin in critically ill patients. Int J Antimicrob Agents. 2018;52:158\u201365. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.008.","journal-title":"Int J Antimicrob Agents"},{"key":"690_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijantimicag.2013.06.006","volume":"42","author":"A Di Paolo","year":"2013","unstructured":"Di Paolo A, Tascini C, Polillo M, Gemignani G, Nielsen EI, Bocci G, et al. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections. Int J Antimicrob Agents. 2013;42:250\u20135. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.06.006.","journal-title":"Int J Antimicrob Agents"},{"key":"690_CR21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s10156-013-0559-z","volume":"19","author":"M Falcone","year":"2013","unstructured":"Falcone M, Russo A, Cassetta MI, Lappa A, Tritapepe L, D\u2019Ettorre G, et al. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: Is therapeutic drug monitoring necessary? J Infect Chemother. 2013;19:732\u20139. https:\/\/doi.org\/10.1007\/s10156-013-0559-z.","journal-title":"J Infect Chemother"},{"key":"690_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1128\/AAC.35.4.696","volume":"35","author":"MJ Rybak","year":"1991","unstructured":"Rybak MJ, Lerner SA, Levine DP, Albrecht LM, McNeil PL, Thompson GA, et al. Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrob Agents Chemother. 1991;35:696\u2013700.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"690_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1128\/AAC.27.3.285","volume":"27","author":"CH King","year":"1985","unstructured":"King CH, Creger RJ, Ellner JJ. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrob Agents Chemother. 1985;27:285\u201390.","journal-title":"Antimicrob Agents Chemother."},{"key":"690_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jiac.2019.08.017","volume":"26","author":"H Tsukada","year":"2020","unstructured":"Tsukada H, Tsuji Y, Yamashina T, Tsuruta M, Hiraki Y, Tsuruyama M, et al. Pharmacokinetics and pharmacodynamics of daptomycin in a clinical setting. J Infect Chemother. 2020;26:230\u20135. https:\/\/doi.org\/10.1016\/j.jiac.2019.08.017.","journal-title":"J Infect Chemother"},{"key":"690_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01593-19","volume":"64","author":"CR Miller","year":"2020","unstructured":"Miller CR, Dey S, Smolenski PD, Kulkarni PS, Monk JM, Szubin R, et al. Distinct subpopulations of intravalvular methicillin-resistant Staphylococcus aureus with variable susceptibility to daptomycin in tricuspid valve endocarditis. Antimicrob Agents Chemother. 2020;64:1\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"690_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","volume":"73","author":"SE Rudasill","year":"2019","unstructured":"Rudasill SE, Sanaiha Y, Mardock AL, Khoury H, Xing H, Antonios JW, et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73:559\u201370. https:\/\/doi.org\/10.1016\/j.jacc.2018.10.082.","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00690-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-021-00690-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00690-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T08:55:46Z","timestamp":1626944146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-021-00690-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1007\/s13318-021-00690-4","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"14 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by a BlueSky research grant (n. 08072320).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors: none to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures in this study were in accordance with the 1964 Helsinki Declaration (and its amendments). The study was approved by the local ethics committee (protocol number 20200006979).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"A written informed consent was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Avaliability of data and materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conceptualization: ES, SDG ADS. Methodology: MDM. Validation: SDG, VM. Formal analysis: ADS. Investigation: AB, IG, MC, SB. Writing\u2014original draft preparation: ES, SDG, RB. Writing\u2014review and editing: RB. Supervision: ES.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}